Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Neurobiology of Aging|March 14, 2012
Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's diseaseSara Rollinson, Nicola Halliwell, Kate Young, et al.Journal of Clinical and Translational Science|August 4, 2026
A case study in teaching and learning the design, conduction, and analysis of Bayesian adaptive trials through an applicationNaima Alam, Alexandra Brown, Xiaosong Shi, et al.Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.Family Practice|August 22, 2022
Implementing a home-based virtual hypertension programme-a pilot feasibility studyAditi Gupta, Shellie D Ellis, Crystal Burkhardt, et al.Cancers|December 30, 2025
Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare SystemBenjamin Schroeder, Prakrit Prasad, Ope Gbadegesin, et al.Neurobiology of Aging|January 18, 2015
Small deletion in C9orf72 hides a proportion of expansion carriers in FTLDSara Rollinson, Janis Bennion Callister, Kate Young, et al.Gut|September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumoursKate Young, Rita T Lawlor, Chanthirika Ragulan, et al.Contemporary Clinical Trials|September 18, 2024
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist controlCarol J Fabian, Dinesh Pal Mudaranthakam, Byron Gajewski, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2026
Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor-induced colitisHajir Ibraheim, Paolo Davide d'Arienzo, Nathan James Dean, et al.Journal for Immunotherapy of Cancer|January 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case seriesCatriona Harvey, Kazi J Nahar, Janet McKeown, et al.Pageof 12